<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Psychiatric pharmacogenomics</title>
  </titleInfo>
  <name type="personal">
    <namePart>Mrazek, David.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">nyu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">New York</placeTerm>
    </place>
    <publisher>Oxford University Press</publisher>
    <dateIssued>2010</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>x, 265 p. : ill. (some col.) ; 25 cm.</extent>
  </physicalDescription>
  <tableOfContents>The language of molecular genetics -- The fourteen genes -- The problem and the solution -- The cytochrome P450 2D6 gene -- The cytochrome P450 2C19 gene -- The cytochrome P450 2C9 gene -- The cytochrome P450 1A2 gene -- The catechol-o-methyltransferase gene -- The norepinephrine transporter gene -- The dopamine transporter gene -- The serotonin transporter gene -- The serotonin 1A receptor gene -- The serotonin 2A receptor gene -- The serotonin 2C receptor gene -- The dopamine D2 receptor gene -- The dopamine D3 receptor gene -- The dopamine D4 receptor gene -- The clinical utility of psychiatric pharmacogenomic testing -- Ethical issues to consider when using pharmacogenomic testing in psychiatric practice -- The future development of psychiatric pharmacogenomic testing.</tableOfContents>
  <note type="statement of responsibility">David A. Mrazek.</note>
  <note>Includes bibliographical references and index.</note>
  <subject authority="lcsh">
    <topic>Psychotropic drugs</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Pharmacogenomics</topic>
  </subject>
  <subject authority="mesh">
    <topic>Biotransformation</topic>
    <topic>genetics</topic>
  </subject>
  <subject authority="mesh">
    <topic>Psychotropic Drugs</topic>
    <topic>adverse effects</topic>
  </subject>
  <subject authority="mesh">
    <topic>Mental Disorders</topic>
    <topic>drug therapy</topic>
  </subject>
  <subject authority="mesh">
    <topic>Psychotropic Drugs</topic>
    <topic>pharmacokinetics</topic>
  </subject>
  <classification authority="lcc">RM315 .M73 2010</classification>
  <classification authority="lcc">RM315 .M73 2010</classification>
  <classification authority="ddc" edition="22">615.788 MDP</classification>
  <classification authority="nlm">QV 38 M939p 2010</classification>
  <identifier type="isbn">9780195367294 (alk. paper)</identifier>
  <identifier type="isbn">0195367294 (alk. paper)</identifier>
  <identifier type="lccn">2009027407</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">DNLM/DLC</recordContentSource>
    <recordCreationDate encoding="marc">090701</recordCreationDate>
    <recordChangeDate encoding="iso8601">20150408114107.0</recordChangeDate>
    <recordIdentifier source="OCoLC">421361492</recordIdentifier>
  </recordInfo>
</mods>
